MARKSANS PHARMA
Back to Cashflow Statement
|
MARKSANS PHARMA Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹-65 Cr | ₹-69 Cr | ₹198 Cr | ₹80 Cr | ₹-15 Cr |
What is the latest Cash Flow from Financing Activities ratio of MARKSANS PHARMA ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹-65 Cr |
| Mar2024 | ₹-69 Cr |
| Mar2023 | ₹198 Cr |
| Mar2022 | ₹80 Cr |
| Mar2021 | ₹-15 Cr |
How is Cash Flow from Financing Activities of MARKSANS PHARMA Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-65 Cr | Negative | |
| Mar2024 | ₹-69 Cr | Negative | |
| Mar2023 | ₹198 Cr | 148.81 | |
| Mar2022 | ₹80 Cr | Positive | |
| Mar2021 | ₹-15 Cr | - | |
Compare Cash Flow from Financing Activities of peers of MARKSANS PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MARKSANS PHARMA | ₹8,139.5 Cr | -0.5% | 6.9% | -17.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹400,497.0 Cr | -1.4% | -6.2% | -1.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹166,939.0 Cr | -0.1% | 2.3% | 9.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹138,109.0 Cr | -1.8% | -4.9% | 28.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,578.0 Cr | -0.4% | -6% | 5.3% | Stock Analytics | |
| CIPLA | ₹99,761.1 Cr | 0.4% | -2.6% | -17.6% | Stock Analytics | |
MARKSANS PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MARKSANS PHARMA | -0.5% |
6.9% |
-17.1% |
| SENSEX | 0.5% |
3.2% |
2.3% |
You may also like the below Video Courses